Results 111 to 120 of about 10,225 (197)

A call for action: Closing the evidence gap in management of stimulant‐induced psychosis

Addiction, EarlyView.
Abstract Background Stimulant‐induced psychosis (StIP) is emerging as one of most pressing health challenges. Over the past two decades, stimulant‐related harms and psychiatric care demands have risen sharply. Individuals with StIP often present with severe agitation and high suicide risk, and up to half progress to chronic psychotic illness within two
Anne Bouthillier, Heidar Sharafi, Adam Bisaga, Didier Jutras‐Aswad   +3 more
wiley   +1 more source

Comparative effectiveness, safety and acceptability of pharmacological and psychosocial interventions for the treatment of cannabis use disorder: A network meta‐analysis

Addiction, EarlyView.
Abstract Aim Our primary aim was to conduct a network meta‐analysis (NMA) for the effectiveness, safety and acceptability of all psychosocial interventions and all pharmacotherapies for cannabis use disorder (CUD). Methods We conducted a NMA of studies identified from two completed systematic reviews examining the effectiveness, safety and ...
Monika Halicka, Francesca Spiga, Tom P. Freeman, Suzanne Nielsen, Jelena Savović, Julian P. T. Higgins, Deborah M. Caldwell   +6 more
wiley   +1 more source

Through the lens of schizophrenia: Recognizing negative facial expressions and family patterns. [PDF]

Schizophr Res Cogn
Shateri L, Yari Renani H, Rudsari AB, Nosratabad TH, Saeidi Z.   +4 more
europepmc   +1 more source

Substance‐related intrusive memories in cocaine use disorder are different from but associated with craving

Addiction, EarlyView.
Abstract Background and aims Cocaine use disorder (CUD) is a significant global health concern, characterized by persistent craving despite severe consequences. Recent theories highlight maladaptive memory processes – such as intrusive, vivid recollections of past substance use that arise spontaneously in daily life – as key contributors to craving and
Amelie Zacher, Lina Dietiker, Victoria Häffner, Francesco Bavato, Birgit Kleim, Boris B. Quednow   +5 more
wiley   +1 more source

Self‐harm in individuals with substance use disorders: Predictive factors and risk model

Addiction, EarlyView.
Abstract Background and aims Substance use disorders are associated with an elevated risk of self‐harm. Currently, clinical and structured assessment of self‐harm risk typically relies on evidence from the general population samples. The aim of this study was to develop a risk model for self‐harm that incorporates predictors specific to individuals ...
Rongqin Yu, Derek K. Tracy, Julia Sinclair, Isabell Brikell, Paul Lichtenstein, Henrik Larsson, Seena Fazel   +6 more
wiley   +1 more source

Mapping research themes and collaborative networks in schizophrenia genetics and clinical psychological correlates: A bibliometric and scientometric study (1957-2025). [PDF]

Medicine (Baltimore)
Naeim M, Naeim M, Narimani M, Aghajani S.   +3 more
europepmc   +1 more source

Comparative effectiveness of alternative times to opioid agonist treatment taper initiation on taper completion and all‐cause mortality among people with opioid use disorder: A retrospective population‐based target trial emulation study in British Columbia, Canada, 2010–2020

Addiction, EarlyView.
Abstract Background and aims Opioid use disorder (OUD) treatment guidelines worldwide recommend opioid agonist treatment (OAT) as a long‐term, potentially indefinite treatment for managing OUD. However, many individuals express a strong interest in eventually tapering fully off treatment.
Ruyu Yan, Jeong Eun Min, Megan Kurz, Shaun R. Seaman, Paxton Bach, Sander Greenland, Paul Gustafson, Mohammad Ehsanul Karim, Lawrence McCandless, Robert William Platt, Uwe Siebert, María Eugenia Socías, Hui Xie, Bohdan Nosyk   +13 more
wiley   +1 more source

Toward a humanized technology: a reinterpretation of Erich Fromm' s humanistic peace psychology. [PDF]

Front Psychol
Wang Y, Li P, Liu W.
europepmc   +1 more source

Dynamics of Body Composition and Metabolic Risk in Adolescents With Obesity Under GLP‐1 Receptor Agonist Therapy

Acta Paediatrica, EarlyView.
ABSTRACT Aim To explore changes in body composition in adolescents with obesity treated with glucagon‐like peptide‐1 receptor agonist (GLP‐1 RA) and their association with metabolic syndrome (MetS) components. Methods This real‐world retrospective study included adolescents (12–18 years) with obesity who received multidisciplinary lifestyle‐based ...
Adar Lopez, Liat Perl, Eyal Cohen‐Sela, Ophir Borger, Yael Issan, Hagar Interator, Erez Azoulay, Hadar Moran‐Lev, Ronit Lubetzky, Shira Zelber‐Sagi, Yael Lebenthal, Avivit Brener   +11 more
wiley   +1 more source

Erratum: Meaningfulness and attachment: what dreams, psychosis and psychedelic states tell us about our need for connection. [PDF]

Front Psychol
Frontiers Production Office.
europepmc   +1 more source